investor.ausbil.com.au
Welcome to Ausbil Investor Web Site
Welcome to the Ausbil Investor website. Now that you have registered you will need to Login. Please note that you can login to Ausbil Investor from a web browser on any computer anywhere. How do I get Access? Having trouble logging in. To login to Ausbil Investor:. 1 In the appropriate fields, type in your email address and put in a password. 2 Click the 'Sign In' button. If the supplied details are correct, you will be logged into your secure Ausbil Investor session.
investor.auspexpharma.com
Investor Relations - Auspex Pharmaceuticals
For Patients and Family. Auspex's lead compound, SD-809, is being developed for the treatment of the involuntary movements that characterize several neurological disorders including Huntington's Disease, Tourette Syndrome and Tardive Dyskinesia. Auspex (Nasdaq: ASPX) was founded in 2001 and is headquartered in San Diego, California. 4:00 PM ET on May 4, 2015. Delayed at least 20 minutes. May 5, 2015. Teva Completes Acquisition of Auspex Pharmaceuticals. Mar 30, 2015. View all press releases ».
investor.austal.com
Company Overview :: Investors :: Austal
Austal - Leading the World in the Design and Construction of Customised Aluminium Commercial and Defence Vessels. Our People in Action. Customer / Operator Links. Leisure and Tourism Products. Careers at Austal Australia. Careers at Austal USA. Inspired by the diversity of our customers and the challenge to exceed their expectations, Austal has, for over 25 years, designed, delivered and supported an unrivalled portfolio of high performance commercial and defence ships. Customer / Operator Links.
investor.autobytel.com
Overview >
Autobytel Inc. (NASDAQ: ABTL. View all ». Aug 6, 2015. Autobytel Reports Second Quarter 2015 Results. Jul 24, 2015. Autobytel to Hold Second Quarter Conference Call on Thursday, August 6, 2015 at 5:00 pm ET. Jul 21, 2015. Autobytel Sponsors Working Wardrobes and VetNet to Help Veterans Find Jobs and Achieve Self-Sufficiency. Onclick="window.open('http:/ delicious.com/save? V=5&noui&jump=close&url=http:/ investor.autobytel.com/index.cfm? U=http:/ investor.autobytel.com/index.cfm? Liolios Group, Inc.
investor.automic.com.au
Automic Registries
A browser upgrade is required. We have detected that you are using an older version of Internet Explorer which isn’t supported. Please click here. To upgrade to the latest version, or download a compatible browser using the icons below.
investor.aveooncology.com
For Investors | Aveo
Scientific Publications and Presentations. AVEO Oncology is a biopharmaceutical company committed to developing targeted therapies through biomarker-driven insights to provide substantial improvements in patient outcomes where significant unmet medical needs exist. AVEO’s proprietary Human Response Platform has delivered unique insights into cancer and related disease biology that are being leveraged in the clinical development of its therapeutic candidates. 160; 0.03. 08/07/15 4:00 pm ET.
investor.avinc.com
Investor Relations - AeroVironment, Inc.
Battery and Fuel Cell Systems. Clean Energy and Water. Digital Data Link (DDL). AV Decision Support System (DSS). Energy, Transportation and Infrastructure. AV Decision Support System (DSS). EV Solutions for Business. EV Solutions for Home. Industrial Charging for MHE. Industrial Charging for GSE. Power Cycling and Test Systems. Mar 26, 2018. AeroVironment Releases New Puma 3, Upgraded for Operation in More Challenging Radio Frequency Environments. Mar 6, 2018. View all press releases ». Jun 26, 2018.
investor.avistacorp.com
Avista Corp - Investor Relations - Welcome to Investor Relations
Find us on Facebook. Follow us on Twitter. Connect with us on LinkedIn. Welcome to Investor Relations. Q2 2015 Avista Corporation Earnings Conference Call. 160;at 7:30 am PT. As an investor-owned company, Avista Corp. is committed to providing its shareholders with easy access to information about the company and to services available to maintain their investment. Thank you for your interest in Avista Corp. 160; 0.30. 08/07/15 4:00 pm ET. Minimum 20 minute delay. There are currently no events scheduled.
investor.avoncompany.com
IRWeblink
Thank you for your interest in IR Solutions. You have reached this page because the URL you have requested is no longer available, or you do not have permission to view it. For more information on the most comprehensive IR web site management tool available, please click here. If you have any questions, e-mail IRSupport@snl.com. Or call (866) 802-9128 and ask for an IR Solutions sales representative. To return to the main SNL Financial homepage.
investor.axcelis.com
Axcelis | Investor Relations - Overview
Spare Parts and Consumables. Investor Presentation and Investor Kit. Investor Presentation and Investor Kit. For thirty five years, Axcelis Technologies has delivered vital equipment, services and process expertise to the semiconductor manufacturing industry, helping customers reach higher levels of productivity with each new technology generation. 08/04/15 - 4:01 pm. Axcelis Announces Financial Results For Second Quarter 2015. 07/13/15 - 8:00 am. 07/09/15 - 8:00 am. 160;at 5:00 pm ET.
investor.axfood.se
Finansiell info
Raquo; Investor Relations. Raquo; Finansiell översikt. Raquo; Risk och riskhantering. Raquo; Marknad och konkurrenter. Raquo; IR kontakt. Raquo; Ordlista och definitioner. Vår ambition är att du ska finna den information som behövs för att bedöma Axfood-aktien som placering. Tveka därför inte att kontakta oss om Du saknar något i vår kommunikation. För Investor Relations, vänligen kontakta IR-kontakt@axfood.se. Delårsrapport Axfood AB 1 jan - 31 jun 2015. Delårsrapport Axfood AB 1 jan - 31 mar 2015.
